Filgrastim Completed Phase 4 Trials for Neonatal Sepsis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01479114Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on CD11b in Septic Neonates